On(b)(6) 2023, a patient (pt) reported a diagnosis of corneal ulcer in the left eye (os) after sleeping in acuvue® oasys® contact lenses (cls) "for a few days while cleaning out a dusty, dirty place" in october 2021.The pt was prescribed an antibiotic eye drop (name and frequency of use not provided) from a compound pharmacy and stated the ulcer healed with no permanent damage.The pt did not know the location of the ulcer on the cornea.The pt was first seen by an eye care professional (ecp) who prescribed the cls and was later referred to an ophthalmologist.On (b)(6) 2023, a call was placed to the pt¿s treating ecp¿s office.The pt was seen on (b)(6) 2021 and was diagnosed with an os corneal ulcer.The pt was prescribed ofloxacin 1 drop every 2 hours (q2h) for 2 days.The pt was seen for follow-up visit on (b)(6) 2021, advised to discontinue cl wear until instructed, and report any changes.The pt was directed to continue eye drops as directed and referred to a corneal specialist.On (b)(6) 2023, a call was placed to the corneal specialist's office.(b)(6) 2021 initial visit: the pt was seen on referral with complaints of eye irritation and a "sore in the eye." the pt was diagnosed with os keratitis, infectious, with slow response to ofloxacin, corneal ulcer, peripheral os, and cataract nuclear sclerosis.The pt was prescribed tobramycin 14 ml/g and fortified cefazolin 50mg, ¿switch drops every 1/2 hour while awake.¿ the pt was instructed to use both drops every 5 minutes for the first hour when waking as a loading dose and follow-up (f/u) in 1 day.(b)(6) 2021 f/u visit: the pt presented with complaints of photophobia and sore eye.The pt reported that the fortified cefazolin was not going to be available from the pharmacy until today, (b)(6) 2021.The pt was advised to begin using medication as directed.(b)(6) 2021 f/u visit: the pt started the medications and was instructed to f/u the next day.24oct2021 f/u visit: the pt reported the eye was "slightly better" after using the meds.The epithelial defect was "down from 3mm to 1mm." the pt was instructed to continue medications as directed.(b)(6) 2021 f/u visit: improving, still using meds q1h while awake and q2h during sleeping hours.The pt was instructed to continue medications as directed.(b)(6) 2021 f/u visit: improving, redness from the eye drops.The pt was instructed to continue medications q1h while awake.(b)(6) 2021 f/u visit: the pt complained os still hurt, and still had ¿fuzzy vision.¿ the pt was instructed to continue medication q1h while awake with ¿loading dose each morning.¿ (b)(6) 2021 f/u visit: the pt was given a sample of besivance to use four times a day (qid), and stated "feels smaller, less light sensitivity but still blurry vision." the pt was instructed to continue medications as directed and was given 1 drop lotemax while in the office.(b)(6) 2021 f/u visit: the pt was instructed to continue with tobramycin and cefazolin q1h while awake and q2h during sleeping hours; besivance qid.Dose of lotemax was given to the pt in office.(b)(6) 2021 f/u visit: the pt reported compliance with tobramycin, cefazolin, and besivance.The pt reported feeling much better "but can feel it and eye is very red." the pt was instructed to decrease tobramycin from q1h to qid; besivance qid; lotemax qid.On (b)(6) 2023, an employee at the corneal specialist's office provided additional information.(b)(6) 2021 f/u visit: the pt reported noted improvement; good compliance with tobramycin, cefazolin, besivance and lotemax.The exam showed os stable, and pt was instructed to decrease fortified tobramycin to q2h, cefazolin qid; besivance qid; lotemax at bedtime.(b)(6) 2021 f/u visit: the pt was instructed to decrease fortified tobramycin to qid, ¿cpm;¿ continue lotemax at bedtime; discontinue cefazolin and besivance.(b)(6) 2021 f/u visit: the pt complained of mild scratchy redness, using over-the-counter gentile gel, and vision "seems stable." the pt was instructed to discontinue all drops and only wear cl daily wear as needed, trying 1 hour at a time.The pt was warned not to sleep in cls.The pt's ulcer healed with a corneal scar.A culture was negative for aerobic organisms; other results pending.The pt was instructed to return next year for a routine eye exam.No additional medical information has been received.The suspect os lot number is unknown.The os suspect cl was discarded.No additional evaluation can be conducted.If any further relevant information is received, a supplemental report will be filed.
|